All Research on Pharmaceutical Manufacturers in Europe

Insight

Report
Report

Profitability Assessment of Branded Generic Inhalers

In this report, we provide a regulatory and economic analysis in Europe and the US of branded generic inhalers.

Published By Datamonitor
$9500
Buy
Case Studies
Case Studies

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

This case study looks at Teva's operations and the market in which it operates, Copaxone, Teva's best-selling drug, and M&A activity Teva has been involved in over recent years, and whether or not it has been successful.

Published By MarketLine
$495
Buy
Case Studies
Case Studies

Orphan Drugs: Rescue from the patent cliff

Big Pharma has gone through some significant changes in recent years: many “blockbuster” drugs are losing their patents. In the orphan drugs market, where companies can charge high premiums for drugs which have little to no competition.

Published By MarketLine
$495
Buy

View all Insight >>

Profiles

Company Profile
Company Profile

Almirall S.A.

Almirall (or 'the group') is principally engaged in the research, development, storage, and commercialization of proprietary drugs as well as licensed products. Its products are sold in over 70 countries, with a direct presence in Europe, the US and Mexico. Almirall is headquartered in Barcelona, Spain, and employed about 2,130 people as of December 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Novo Nordisk A/S

Novo Nordisk (or 'the company') is a leading global provider of diabetes products. The company also has a leadership position in hemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk operates in Europe, North America, China, Japan, Korea and other regions of the world. It is headquartered in Bagsvaerd, Denmark, and employed 41,450 people as of December 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Krka, d. d., Novo mesto

Krka, d. d., Novo mesto (Krka or 'the group'), is a Slovenia-based provider of prescription pharmaceuticals, self-medication products, and animal health products. The group is also engaged in the health resort business and providing tourist services. The group primarily operates in Europe. It is headquartered in Novo Mesto, Slovenia and employed 10,499 people as of December 31, 2014.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.